Immediate Impact
53 standout
Citing Papers
Non-small-cell lung cancer
2024 Standout
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
2024 Standout
Works of Michael A. Samuels being referenced
A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non–Small-Cell Lung Cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)
2014
Phase II Trial of Combined Modality Therapy with Myeloid Growth Factor Support in Patients with Locally Advanced Non-small Cell Lung Cancer
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Michael A. Samuels | 101 | 152 | 133 | 34 | 400 | |
| Hanjie Shen | 95 | 130 | 96 | 27 | 372 | |
| Emanuela Olmetto | 107 | 132 | 191 | 36 | 397 | |
| Xiao‐Dong Zhu | 202 | 138 | 138 | 41 | 457 | |
| M.J. Tennapel | 106 | 82 | 101 | 40 | 409 | |
| Stefania Vecchio | 227 | 157 | 179 | 28 | 430 | |
| Ceri Powell | 87 | 118 | 100 | 22 | 340 | |
| Pragya Shukla | 41 | 86 | 128 | 43 | 380 | |
| Brock Debenham | 142 | 108 | 122 | 38 | 379 | |
| Helena Regina Cômodo Segreto | 108 | 62 | 182 | 38 | 417 | |
| David Skarsgard | 113 | 109 | 203 | 25 | 437 |
All Works
Login with ORCID to disown or claim papers
Loading papers...